Hepatitis B Treatment (cont.)
IN THIS ARTICLE
New nucleoside/nucleotide analogues are being developed to try to improve outcomes or limit side effects or resistance in hepatitis B. One example is emtricitabine (Emtriva), which is already approved for use in HIV. Other examples include clevudine (L-FMAU), pradefovir, alamifovir, valtorcitabine, and medications that are currently identified only with drug numbers such as ANA380 (LB80380), ANA-975, and others.
Although currently available vaccines against hepatitis B are not effective in patients who already have chronic hepatitis B, new vaccines are being developed that may one day help stimulate the body's immune system in combination with medical treatment.
Combination therapies using two nucleoside/nucleotide analogues or analogues plus pegylated interferon have not shown superiority to single-agent therapy.
For More Information
Hepatitis B Foundation
Medically reviewed by Robert Cox, MD; American Board of Internal Medicine with subspecialty in Infectious Disease
Medically Reviewed by a Doctor on 7/30/2014
Must Read Articles Related to Hepatitis B Treatment
Patient Comments & Reviews
The eMedicineHealth doctors ask about Hepatitis B Treatment:
Hepatitis B - Treatment
What treatment did you receive for your Hepatitis B?